Neoantigen landscape supports feasibility of personalized cancer vaccine for follicular lymphoma

Authors

• Cody A Ramirez, Washington University School of Medicine in St. Louis
• Michelle Becker-Hapak, Washington University School of Medicine in St. Louis
• Kartik Singhal, Washington University School of Medicine in St. Louis
• David A Russler-Germain, Washington University School of Medicine in St. Louis
• Erica K Barnell, Washington University School of Medicine in St. Louis
• Ethan D McClain, Washington University School of Medicine in St. Louis
• Sweta Desai, Washington University School of Medicine in St. Louis
• Timothy Schappe, Washington University School of Medicine in St. Louis
• Onyinyechi C Onyeador, Washington University School of Medicine in St. Louis
• Susanna Kiwala, Washington University School of Medicine in St. Louis
• Jasreet Hundal, Washington University School of Medicine in St. Louis
• Zachary L Skidmore, Washington University School of Medicine in St. Louis
• Marcus P Watkins, Washington University School of Medicine in St. Louis
• Thomas B Mooney, Washington University School of Medicine in St. Louis
• Jason R Walker, Washington University School of Medicine in St. Louis
• Kilannin Krysiak, Washington University School of Medicine in St. Louis
• Felicia Gomez, Washington University School of Medicine in St. Louis
• Catrina C Fronick, Washington University School of Medicine in St. Louis
• Robert S Fulton, Washington University School of Medicine in St. Louis
• Robert D Schreiber, Washington University School of Medicine in St. Louis
• Neha Mehta-Shah, Washington University School of Medicine in St. Louis
• Amanda F Cashen, Washington University School of Medicine in St. Louis
• Brad S Kahl, Washington University School of Medicine in St. Louis
• Nancy L Bartlett, Washington University School of Medicine in St. Louis
• Malachi Griffith, Washington University School of Medicine in St. Louis
• Obi L Griffith, Washington University School of Medicine in St. Louis
• Todd A Fehniger, Washington University School of Medicine in St. Louis
• et al.

Journal

Blood Advances

Publication Date

8-13-2024

Volume

8

Issue

15

First Page

4035

Last Page

4049

Document Type

Open Access Publication

DOI

10.1182/bloodadvances.2022007792

Rights and Permissions

Ramirez CA, Becker-Hapak M, Singhal K, Russler-Germain DA, Frenkel F, Barnell EK, McClain ED, Desai S, Schappe T, Onyeador OC, Kudryashova O, Belousov V, Bagaev A, Ocheredko E, Kiwala S, Hundal J, Skidmore ZL, Watkins MP, Mooney TB, Walker JR, Krysiak K, Gomez F, Fronick CC, Fulton RS, Schreiber RD, Mehta-Shah N, Cashen AF, Kahl BS, Ataullakhanov R, Bartlett NL, Griffith M, Griffith OL, Fehniger TA. Neoantigen landscape supports feasibility of personalized cancer vaccine for follicular lymphoma. Blood Adv. 2024 Aug 13;8(15):4035-4049. doi: 10.1182/bloodadvances.2022007792. © 2024 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.

Recommended Citation

Ramirez, Cody A; Becker-Hapak, Michelle; Singhal, Kartik; Russler-Germain, David A; Barnell, Erica K; McClain, Ethan D; Desai, Sweta; Schappe, Timothy; Onyeador, Onyinyechi C; Kiwala, Susanna; Hundal, Jasreet; Skidmore, Zachary L; Watkins, Marcus P; Mooney, Thomas B; Walker, Jason R; Krysiak, Kilannin; Gomez, Felicia; Fronick, Catrina C; Fulton, Robert S; Schreiber, Robert D; Mehta-Shah, Neha; Cashen, Amanda F; Kahl, Brad S; Bartlett, Nancy L; Griffith, Malachi; Griffith, Obi L; Fehniger, Todd A; and et al., "Neoantigen landscape supports feasibility of personalized cancer vaccine for follicular lymphoma." Blood Advances. 8, 15. 4035 - 4049. (2024).
https://digitalcommons.wustl.edu/oa_4/4110

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.